Pilot trial of EZN-2968, an antisense oligonucleotide inhibitor of hypoxia-inducible factor-1 alpha (HIF-1α), in patients with refractory solid tumors
暂无分享,去创建一个
S. Steinberg | P. Choyke | J. Doroshow | A. Chen | B. Turkbey | G. Melillo | S. Kummar | A. Rapisarda | Sook Ryun Park | R. Kinders | W. Jeong